Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 140.61
+3.64 (2.66%)
At close: Jan 27, 2026
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 125.85 billion as of January 29, 2026. Its market cap has increased by 36.50% in one year.
Market Cap
125.85B
Enterprise Value
136.28B
Revenue
21.64B
Ranking
n/a
PE Ratio
20.86
Stock Price
140.61
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 125.85B, an increase of 90,619.32%. That is a compound annual growth rate of 22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 125.85B | 11.23% |
| Dec 31, 2025 | 113.14B | 23.05% |
| Dec 31, 2024 | 91.95B | 16.03% |
| Dec 29, 2023 | 79.25B | -11.32% |
| Dec 30, 2022 | 89.37B | 32.86% |
| Dec 31, 2021 | 67.26B | 25.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 215.81B |
| AstraZeneca | 209.50B |
| Shell | 155.52B |
| Rio Tinto Group | 113.80B |
| Unilever | 106.63B |
| Rolls-Royce Holdings | 101.00B |
| British American Tobacco p.l.c. | 94.03B |
| GSK plc | 72.92B |